Issue StoriesDouble Check: A Closer Look at CADby Lisa Fratt Sponsored by an educational grant from R2 Technology. As much as 20 to 40 percent of breast cancer cases are not detected at the screening stage. Computer-aided detection (CAD) has helped fill the gap very well, making it an attractive option to enhance cancer treatment.
But there is good news. The other side of the story shows radiology departments and breast imaging centers throughout the country finding that investing in computer-aided detection (CAD) can make a significant difference in their practice. R2 Technology, Inc.s (Sunnyvale, Calif.) ImageChecker system for mammography provides radiologists with a second set of eyes by highlighting suspicious areas on a mammogram. The system can reduce the false negative rate, detecting subtle cancers that even the most experienced radiologist might miss. Moreover, centers that have purchased the ImageChecker find that it boosts patient confidence.
On the financial front, Medicare is reimbursing for mammography CAD, making it possible for a growing number of centers that have purchased the ImageChecker to cover the cost of the technology and even realize a return on their investment. More importantly, a number of private payors are following suit. It is, however, a testament to the technology that many women are willing to pay out of pocket for an additional computer reading. Foster & Gross Radiology (Laurel Springs, N.J.), which charges its patients for the service, reports that women will visit from up to 50 miles away for a mammography screening with the aid of the ImageChecker CAD system. In the radiology world, everyone does seem to agree on one thing: mammography isnt perfect. Retrospective studies reported in the New England Journal of Medicine, Archives of Internal Medicine and American Journal of Roentgenology have shown that 20 to 50 percent of breast cancers go undetected at the screening stage. Approximately half of the undetected cancers are missed due to observational oversights normally caused by fatigue. CAD technology can significantly reduce the incidence of false negative readings, which may, in turn, translate into a higher percentage of early stage cancer detections and greatly improved survival rates. A clinical trial of R2s ImageChecker system and re-analyses of updated software have demonstrated that use of the ImageChecker could result in earlier detection of up to 23.4 percent of the cancers currently detected with screening mammography in those women who had a prior screening mammogram nine to 24 months earlier. Please refer to the May 2002 issue for the complete story. For information on article reprints, contact Martin St. Denis |
|
|
ADDITIONAL ONLINE RESOURCES |
|